Low risk of IOP elevations found with drug combination.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      INTRAOCULAR pressure; TOBRAMYCIN; STEROID drugs; OPHTHALMIC drugs; HOLLAND, Edward J.
    • Abstract:
      The article reports on a study that the combination of loteprednol etabonate/tobramycin produce lower levels of steroid-induced intraocular pressure (IOP) rise compared to dexamethasone/tobramycin combination. According to Edward J. Holland, director of cornea at the Cincinnati Eye Institute, loteprednol is an excellent choice because of its efficacy as a good anti-inflammatory medication.